Stock Events

Stock Events

Galectin Therapeutics (GALT) Q2 2025 Earnings

15MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.2

-0.18

-0.17

-0.15

Details

Expected EPS

-0.2

Actual EPS

-0.15

Surprise EPS

0.05

Surprise Percent

+25%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.15 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.